Bcl-2 Reduced and Fas Activated by the Inhibition of Stem Cell Factor/KIT Signaling in Murine Melanocyte Precursors
- 1 January 2005
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 124 (1) , 229-234
- https://doi.org/10.1111/j.0022-202x.2004.23540.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplantsOncogene, 2003
- Differentiation of Murine Melanocyte Precursors Induced by 1,25-Dihydroxyvitamin D3 Is Associated with the Stimulation of Endothelin B Receptor ExpressionJournal of Investigative Dermatology, 2002
- All-trans Retinoic Acid Induces Differentiation and Apoptosis of Murine Melanocyte Precursors with Induction of the Microphthalmia-Associated Transcription FactorJournal of Investigative Dermatology, 2002
- The Paracrine Role of Stem Cell Factor/c-kit Signaling in the Activation of Human Melanocytes in Ultraviolet-B-Induced PigmentationJournal of Investigative Dermatology, 2001
- The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor functionAnnals of the Rheumatic Diseases, 2000
- Up-Regulation and Redistribution of Bax in Ultraviolet B-Irradiated MelanocytesPigment Cell Research, 2000
- Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligoBritish Journal of Dermatology, 2000
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic EnvironmentAnnual Review of Immunology, 1999
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune EscapeScience, 1996